SRSF5 Antikörper (Middle Region)
Kurzübersicht für SRSF5 Antikörper (Middle Region) (ABIN453374)
Target
Alle SRSF5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Spezifität
- This antibody reacts to SFRS5.
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation
-
Immunogen
- KLH conjugated synthetic peptide selected from the Center region of human SFRS5
-
-
-
-
Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SRSF5 (serine/arginine-Rich Splicing Factor 5 (SRSF5))
-
Andere Bezeichnung
- SFRS5
-
Hintergrund
- SFRS5 plays a role in constitutive splicing and can modulate the selection of alternative splice sites.Synonyms: Delayed-early protein HRS, HRS, Pre-mRNA-splicing factor SRP40, SRP40, Splicing factor arginine/serine-rich 5
-
Gen-ID
- 6430
-
NCBI Accession
- NP_001034554
-
UniProt
- Q13243
-
Pathways
- Ribonucleoprotein Complex Subunit Organization
Target
-